Article
Multifaceted dysregulation of the epidermal growth factor receptor pathway in clear cell sarcoma of the kidney.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2007
Little Suzanne E, Bax Dorine A, Rodriguez-Pinilla Maria, Natrajan Rachael, Messahel Boo, Pritchard-Jones Kathy, Vujanic Gordan M, Reis-Filho Jorge S, Jones Chris
Abstract excerpt
PURPOSE: Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase overexpressed in a variety of human malignancies, against which targeted therapies have shown efficacy in lung and brain tumors. Clinical responses to EGFR inhibitors have been found to be highly dependent on the presence of activating mutations, whereas gene amplification, downstream activation of Akt, and abnormalities in PTEN are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
